Back to 
Candriam S.C.A.
Candriam S.C.A.
MBX2 quarters
Position history for Candriam S.C.A.'s holdings in MBX Biosciences, Inc.
Candriam S.C.A. holds 289,893 shares of MBX (MBX Biosciences, Inc.), worth $16M as of 2026-Q2. The position was decreased (-1.5% shares). MBX represents 0.1% of Candriam S.C.A.'s portfolio.
Current Value
$16M
Current Shares
289,893
Total Value Change
+$7.2M
Total Shares Change
-4,481
Quarter-by-Quarter History
Other major holders of MBX: FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc.